Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.25 |
| Open | 15.15 |
| Bid | 10.91 x 200 |
| Ask | 18.26 x 200 |
| Day's range | 14.20 - 15.38 |
| 52-week range | 3.53 - 17.40 |
| Volume | |
| Avg. volume | 12,478,953 |
| Market cap | 2.214B |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 21.60 |
PR NewswireNovavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
ZacksHere is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Barrons.comArbutus, Novavax See Activist Investor Action
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
© 2024 Yahoo. All rights reserved.